Bank of America
DRTS icon

Bank of America’s Alpha Tau Medical DRTS Stock Holding History

Bank of America’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$249K Sell
19,770
-21,622
-52% -$196K ﹤0.01% 5291
2026
Q1 		$293K Sell
41,392
-2,752
-6% -$19.4K ﹤0.01% 5168
2025
Q4 		$219K Buy
44,144
+21,687
+97% +$91.4K ﹤0.01% 5299
2025
Q3 		$101K Buy
22,457
+21,677
+2,779% +$73.8K ﹤0.01% 6587
2025
Q2 		$2.43K Hold
780
– – ﹤0.01% 7405
2025
Q1 		$1.96K Hold
780
– – ﹤0.01% 7338
2024
Q4 		$2.42K Hold
780
– – ﹤0.01% 7183
2024
Q3 		$1.86K Hold
780
– – ﹤0.01% 7139
2024
Q2 		$1.97K Hold
780
– – ﹤0.01% 7144
2024
Q1 		$2.3K Sell
780
-79
-9% -$243 ﹤0.01% 7110
2023
Q4 		$2.59K Buy
859
+79
+10% +$254 ﹤0.01% 7103
2023
Q3 		$2.96K Hold
780
– – ﹤0.01% 7097
2023
Q2 		$3.41K Hold
780
– – ﹤0.01% 7059
2023
Q1 		$2.24K Buy
780
+770
+7,700% +$2.69K ﹤0.01% 7202
2022
Q4 		$32 Hold
10
– – ﹤0.01% 7886
2022
Q3 		$0 Hold
10
– – ﹤0.01% 7920
2022
Q2 		$0 Hold
10
– – ﹤0.01% 8096
2022
Q1 		$0 Buy
+10
New +$118 ﹤0.01% 8358

Other funds holding DRTS

GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Bank of America's DRTS Position: Q2 2026 in Review

Bank of America reduced its Alpha Tau Medical (DRTS) stake by 52% in Q2 2026, selling an estimated $196K and leaving 19,770 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #5291.

Bank of America first reported a position in DRTS in Q1 2022 and has held it in 18 quarters since. The position peaked at $293K in Q1 2026. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • Bank of America held 19,770 shares of Alpha Tau Medical worth $249K as of Q2 2026.
  • Bank of America sold 21,622 Alpha Tau Medical shares in Q2 2026, an estimated $196K.
  • Alpha Tau Medical made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #5291 holding.
  • Bank of America first reported a position in Alpha Tau Medical in Q1 2022 and has held it in 18 quarters since.
  • Bank of America's Alpha Tau Medical position peaked at $293K in Q1 2026.
  • 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.